Task: Answer the multiple-choice question.
Question: Which compound exhibits a 2.918% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
[a] COc1ccccc1NC(=O)Nc1ccnn1C1CCCCC1
[b] C=CCNc1nc(S(=O)Cc2ccc(C)cc2)nc2c1CCCC2
[c] CC(C)c1ccc(-c2c(C#N)c(N)nc(SCC(=O)N3CCCCCC3)c2C#N)cc1
[d] CCCCN(CC)CCCNC(=O)c1ccc(CSc2nc3ccncc3[nH]2)cc1
[e] CCOC(=O)c1sc(NC(=O)c2cc3n(n2)C(C(F)(F)F)CC(c2cccs2)N3)c(C(=O)OCC)c1C
Answer: d. CCCCN(CC)CCCNC(=O)c1ccc(CSc2nc3ccncc3[nH]2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)CCCNC(=O)c1ccc(CSc2nc3ccncc3[nH]2)cc1
CCCCN(CC)CCCNC(=O)c1ccc(CSc2nc3ccncc3[nH]2)cc1
N-[3-[butyl(ethyl)amino]propyl]-4-(3H-imidazo[4,5-c]pyridin-2-ylsulfanylmethyl)benzamide